Risk

Vigilance in infectious disease emergencies: Expanding the concept – Jane Williams et al.

2024-04-12T12:11:18+10:00COVID-19, Health system, Public comprehension, Publications, Risk|

Protecting the health of the public, during a crisis or otherwise, is almost always considered the responsibility of governments. Analyses of institutional responses to the COVID-19 pandemic illustrate that governments play a central role in the suppression and control of public infection through measures that [...]

Hip-specific and generic patient-reported outcome measure scores after primary hip replacement are associated with early revision surgery: a national registry study – Ilana N. Ackerman et al.

2024-04-12T11:50:43+10:00Hip, Knee, Musculoskeletal, Pain, PROMS, Publications, Risk|

The ability to efficiently identify patients at higher risk of poor outcomes after joint replacement would enable limited resources for post-operative follow-up to be directed to those with the greatest clinical need. This is particularly important as joint replacement rates continue to grow internationally, stretching [...]

Establishing a hierarchy of total knee arthroplasty patients’ goals and its congruity to health professionals’ perceptions: a cohort study – Sascha Karunaratne et al.

2024-04-07T16:49:13+10:00Knee, Musculoskeletal, Osteoarthritis, Pain, Publications, Risk, Shared decision making, Surgery, Treatment|

This study established a hierarchy of the goals most important to patients, identifying key goals as improving mobility, reducing pain, and improving daily tasks. Health professionals involved in the recommendation of knee arthroplasty were generally found to be able to identify what patients wanted to [...]

Exploring Different Contexts of Statin Deprescribing: A Vignette-Based Experiment with Older Adults Across Four Countries – Kristie Rebecca Weir et al.

2024-04-07T16:33:55+10:00Ageing, Deprescribing, Polypharmacy, Primary Care, Publications, Risk|

Deprescribing is the process of a healthcare professional reducing or stopping an inappropriate medication. Statins, commonly prescribed to prevent cardiovascular events, pose uncertain benefits and potential harms for older adults, making deprescribing a preference-sensitive decision. Deprescribing studies typically ask general questions about deprescribing preferences; however, [...]

Association of state-level prescription drug monitoring program implementation with opioid prescribing transitions in primary care in Australia – Ting Xia et al.

2024-04-07T14:41:17+10:00Clinical guidelines, Deprescribing, Opioids, Pain, Prescribing, Primary Care, Publications, Risk|

This study aimed to evaluate whether voluntary and mandatory prescription drug monitoring program (PDMP) use in Victoria, Australia, had an impact on prescribing behaviour, focusing on individual patients' prescribed opioid doses and transition to prescribing of nonmonitored medications.

Benefits and harms of prostate specific antigen testing according to Australian guidelines – Michael Caruana et al.

2024-04-07T12:52:52+10:00Cancer, Overdiagnosis, Prostate cancer, Publications, Risk, Screening, Tests|

Guidelines for prostate specific antigen (PSA) testing in Australia recommend that men at average risk of prostate cancer who have been informed of the benefits and harms, and who decide to undergo regular testing, should be offered testing every 2 years from 50 to 69 years. This [...]

Could nudges reduce health literacy disparities in CVD prevention? An experiment using alternative messages for CVD risk assessment screening – Michael Anthony Fajardo et al.

2024-04-05T14:58:38+11:00Cardiovascular disease, General Practice, Health literacy, Publications, Risk, Screening|

This study aimed to test different SMS messages inviting patients for a Heart Health Check with their GP. We also assessed how health literacy moderated these effects, to inform an Australian CVD risk screening program. Specifically, we tested a control message used in a previous [...]

‘Integrating Ethics and Equity with Economics and Effectiveness for newborn screening in the genomic age: A qualitative study protocol of stakeholder perspectives – Didu S. Kariyawasam et al.

2024-04-05T14:50:00+11:00Ethical considerations, Genetic testing, Genomics, Health policy, Publications, Risk, Screening|

Newborn bloodspot screening is a well-established population health initiative that detects serious, childhood-onset, treatable conditions to improve health outcomes. With genomic technologies advancing rapidly, many countries are actively discussing the introduction of genomic assays into newborn screening programs. While adding genomic testing to Australia’s newborn [...]

First implantable cardiac defibrillator insertions in New South Wales, 2005–2020: an analysis of linked administrative data – Lin Zhu et al.

2024-04-05T14:44:05+11:00Ageing, Cardiovascular disease, Publications, Risk, Surgery|

Our population-based analysis of linked administrative data found that the annual number of first insertions of ICDs steadily increased in NSW during 2005–2016. Most ICD recipients were men, especially in older age groups, and the rise in annual number was most marked for men aged [...]

Implementing decision aids for cardiovascular disease prevention: stakeholder interviews and case studies in Australian primary care – Carissa Bonner et al.

2024-04-05T14:38:40+11:00Cardiovascular disease, Decision aids, Primary Care, Primary Health Networks, Publications, Risk|

Australian cardiovascular disease (CVD) prevention guidelines recommend absolute CVD risk assessment, but less than half of eligible patients have the required risk factors recorded due to fragmented implementation over the last decade. Co-designed decision aids for general practitioners (GPs) and consumers have been developed that [...]

Go to Top